Kevork Peltekian, MD

Dr. Peltekian, is a hepatologist with the Division of Digestive Care & Endoscopy advocating for Atlantic Canadians with liver disease.

[Kevork Peltekian, MD @LiverSensible]

Coffee: The Original Wonder Drug? http://t.co/GsMuGoHuO9

[Kevork Peltekian, MD @LiverSensible]

I am riding in the Great Cycle Challenge. Please support @sickkids efforts to fight kids' cancer. YES CHILDREN CAN ALSO GET #LiverCancer https://t.co/JsJcsOf5NX

[Kevork Peltekian, MD @LiverSensible]

Check https://t.co/xhjJJe4bjj to see how many Canadian @Hepatologist are EASL member - @EASLnews

[Kevork Peltekian, MD @LiverSensible]

'Alarming' Global Rise in NAFLD https://t.co/XdRdxZphOC via @medscape

[Kevork Peltekian, MD @LiverSensible]

The Doc Project with Acey Rowe - July 10, 2022: Operation Good Times (SUMMER REPEAT) https://t.co/YJjjTbafhB

[Kevork Peltekian, MD @LiverSensible]

This is when you should work out each day to help keep weight off, study suggests
https://t.co/XDHAuFrEdG

[Kevork Peltekian, MD @LiverSensible]

This classic diet change is known to improve health
https://t.co/gqCxKcUA6e

[Kevork Peltekian, MD @LiverSensible]

These ‘healthier’ drinks may do more harm than good
https://t.co/CLVlhK2bOG

[Kevork Peltekian, MD @LiverSensible]

6 seemingly harmless habits that pack on the pounds
https://t.co/7oHeD0b24b

[Kevork Peltekian, MD @LiverSensible]

Dolly Parton Donates Another $1 Million to Infectious Disease Research - CLASSY LADY DOING CLASSY THINGS. https://t.co/DcWwTit7YW via @medscape

[Kevork Peltekian, MD @LiverSensible]

Tirzepatide Once Weekly for the Treatment of Obesity | NEJM - MAYBE THERE IS STILL HOPE TO CONTROL THE FATTY LIVER DISEASE BURDEN https://t.co/xED58Qn4wR

[Kevork Peltekian, MD @LiverSensible]

Mayo Clinic Minute: Gardening grows benefits for body and mind TOTALLY AGREE FROM OWN EXPERIENCE
https://t.co/y3XCj6gKmo

[Kevork Peltekian, MD @LiverSensible]

FDA grants fast track status to ervogastat plus clesacostat for NASH https://t.co/zzTTFavCP1

[Kevork Peltekian, MD @LiverSensible]

Declining Incidence of Hepatitis C Related Hepatocellular Carcinoma in the era of Interferon-free Therapies
https://t.co/7aeZk9pQAa

[Kevork Peltekian, MD @LiverSensible]

No-shows: Why they happen and how to stop them - WISH OUR DEPARTMENT ADOPTS SOME OF THESE
https://t.co/g9sbhT1wJQ

[Kevork Peltekian, MD @LiverSensible]

How to solve Canada's healthcare human resources problems? NOT SURE THIS ISSUE CAN BE SOLVED IF WE DO NOT KNOW WHO IS DOING WHAT IN HEALTH CARE AND WHAT CANADIANS WANT FROM THEIR HEALTHCARE SYSTEM
https://t.co/CS2qSc4cBP

[Kevork Peltekian, MD @LiverSensible]

Gallstone disease may be predictor of pancreatic cancer https://t.co/wem4VVX5Lu

[Kevork Peltekian, MD @LiverSensible]

A sincere thank you to @cibc for their generous donation to @CobequidFound @NSHAcentral FibroScan Campaign. #cobequidcares #cibc #fibroscan #hepatology #thankyou #community #funding #healthcare
https://t.co/I0v3WYhrNs

[Kevork Peltekian, MD @LiverSensible]

Managing workplace humor in healthcare settings
https://t.co/JKHYPy5DHL

[Kevork Peltekian, MD @LiverSensible]

Books by doctors for doctors: Essential reading for summer
https://t.co/LtW3thKdG9

[Kevork Peltekian, MD @LiverSensible]

It's tough to lose weight, survey confirms THAT IS WHY WE HAVE TO FIND OTHER SOLUTIONS FOR #FATTYLIVER DISEASE
https://t.co/iv4jWPTH53